Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 27, 2022
Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation under which Fujifilm will acquire Atara’s T-Cell Operations and Manufacturing (ATOM) ...
read more
Wednesday, October 19, 2016
ATCC, a global provider of biological materials development, management and standards, and BioAgilytix, a provider of contract testing services with a specialization in biologics, have announced a strategic partnership to develop new and custom cell-...
read more
ATCC has entered into an agreement with QIAGEN to provide them with sequencing data from its collection of cell lines, and animal and human biological materials. QIAGEN Digital Insights, the bioinformatics unit of QIAGEN, will establish a database ...
read more
Thursday, October 08, 2020
ATCC announced a potential 10-year, IDIQ contract award with a ceiling value of $250 million from the BARDA, a division of the Office of the Assistant Secretary for Preparedness and Response with the HHS.
read more
Wednesday, September 03, 2025
Atelerix, a cell preservation and biological transport company, announced an agreement with Rodon Global, a freight company focused on clinical trials and drug discovery headquartered in South Africa. The collaboration comes at a pivotal time as ...
read more
Thursday, September 03, 2020
Atelerix has received an award under the UK Innovation and Science Seed Fund (UKI2S) Accelerator Programme from Innovate UK, the UK’s innovation agency.
read more
Thursday, December 27, 2018
Athenex announced the launch of Levothyroxine Sodium for Injection through its subsidiary Athenex Pharmaceutical Division (APD).
read more
AtkinsRéalis Group Inc. an engineering services and nuclear company has been chosen by Jubilant HollisterStier to provide detailed design for the expansion of their sterile injectable facility in Montreal as part of Canada's Biomanufacturing and Life...
read more
Friday, December 10, 2021
ATMPS Ltd/Hataali – a provider of blockchain-based data sharing platforms for advanced therapies – announced a new strategic partnership with Assurea LLC, the USA-based quality and compliance consultancy.
read more
Wednesday, September 02, 2020
Atorus Research has announced the release of their second R package, Tplyr.
read more
Atossa Genetics Inc. has signed manufacturing and quality agreements with AAIPharma Services Corp./Cambridge Major Laboratories, Inc. for the manufacturing of a clinical supply for 4-Hydroxytamoxifen, the API in Atossa's leading drug candidate, ...
read more
Thursday, August 28, 2025
Atossa Therapeutics has selected PSI to operationalize and manage its planned (Z)-endoxifen monotherapy dose-ranging study in women with metastatic breast cancer (mBC). The study was designed following guidance from the FDA and is intended to ...
read more
Monday, September 25, 2017
Atox Bio today announced that it has been awarded the next option on a performance-based contract with the BARDA for the development of Reltecimod in patients with NSTI.
read more
Thursday, January 30, 2025
Atreo, Inc. has announced a strategic preferred partnership with N-SIDE. This collaboration aims to empower pharmaceutical and biotech companies with seamlessly integrated solutions, enabling faster drug development and improved operational ...
read more
Atrin Pharmaceuticals has announced receipt of a Phase 1 Small Business Technology Transfer (STTR) Award (R41CA203436) for approximately $300,000 from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). The award supports ...
read more